Skip to main content

Medical Readiness: Safety and Efficacy of the Anthrax Vaccine

T-NSIAD-99-148 Published: Apr 29, 1999. Publicly Released: Apr 29, 1999.
Jump To:
Skip to Highlights

Highlights

Pursuant to a congressional request, GAO discussed the results of its ongoing examination of the safety and efficacy of the anthrax vaccine, focusing on: (1) the short- and long-term safety of the vaccine; (2) the efficacy of the vaccine; and (3) problems the Food and Drug Administration (FDA) found in the vaccine production facility in Michigan that could compromise the safety, efficacy, and quality of the vaccine.

Full Report

Office of Public Affairs

Topics

Biological warfareBiomedical researchChemical agentsBiological agentsAnthraxChemical warfareImmunization servicesNoncomplianceProduct evaluationProduct safetyPublic health researchQuality controlSafety standards